NovaBridge Biosciences American Insider Trading
NBP
Insiders bought 663K and sold 154K on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan. Chief Bus. Development Officer Sean Wuxiong Cao sold 80K on Sep 9, 29% of their stake, outside a plan.
Get an email when NBP's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Nov 17 – 18 | Mark Arnold Hagler Chief Commercial Officer | Bought 2 parts | 230,000 | $0.37 average | 86K | 100% | Form 4 |
| Sep 18 | Phillip Andrew Dennis Chief Medical Officer | SoldNo plan | 8,209 | $0.71 | 6K | 4.5% | Form 4 |
| Sep 9 | Sean Wuxiong Cao Chief Bus. Development Officer | SoldNo plan | 107,978 | $0.74 | 80K | 29% | Form 4 |
| Aug 31 | Cong Claire Xu EVP, Clinical Development | SoldNo plan | 3,282 | $0.79 | 3K | 1.1% | Form 4 |
| Jul 6 | Cong Claire Xu SVP, Clinical Development | SoldNo plan | 4,485 | $0.89 | 4K | 1.5% | Form 4 |
| Jun 18 | Phillip Andrew Dennis Chief Medical Officer | SoldNo plan | 8,494 | $0.66 | 6K | 5.1% | Form 4 |
| Jun 1 | Cong Claire Xu SVP, Clinical Development | SoldNo plan | 3,494 | $3.94 | 14K | 1.2% | Form 4 |
| May 14 | Sean Wuxiong Cao See Remarks | SoldNo plan | 21,399 | $1.99 | 43K | 38% | Form 4 |
| Apr 24 | Mark Arnold Hagler See Remarks | Bought | 230,000 | $2.51 | 577K | New | Form 4 |
- Nov 17 – 18Mark Arnold HaglerChief Commercial Officer · bought 230,000 at avg $0.3786K100% of stake
- Sep 18No planPhillip Andrew DennisChief Medical Officer · sold 8,209 at $0.716K4.5% of stake
- Sep 9No planSean Wuxiong CaoChief Bus. Development Officer · sold 107,978 at $0.7480K29% of stake
- Aug 31No planCong Claire XuEVP, Clinical Development · sold 3,282 at $0.793K1.1% of stake
- Jul 6No planCong Claire XuSVP, Clinical Development · sold 4,485 at $0.894K1.5% of stake
- Jun 18No planPhillip Andrew DennisChief Medical Officer · sold 8,494 at $0.666K5.1% of stake
- Jun 1No planCong Claire XuSVP, Clinical Development · sold 3,494 at $3.9414K1.2% of stake
- May 14No planSean Wuxiong CaoSee Remarks · sold 21,399 at $1.9943K38% of stake
- Apr 24Mark Arnold HaglerSee Remarks · bought 230,000 at $2.51577KNew position
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biotechnology · Pick stocks to compare with NBP
Held by ETFs
NBP is in 4 US ETFs. The largest of them, with NBP's weight in each:
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing NBP
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.